Chen K, Li J, Wang J, Xia Y, Dai W, Wang F, et al
One of the biggest variations in the different results in publications is because of the varied physiochemical features of liposomes including size, the charge, the composition and the drugs used for the studies
Nonsteroidal antiandrogen monotherapy versus surgical or medical castration A systematic evidence review compared nonsteroidal antiandrogen monotherapy with surgical or medical castration from 11 randomized trials in 3,060 men with locally advanced, metastatic, or recurrent disease after local therapy.[21] The use of nonsteroidal antiandrogens as monotherapy decreased OS and increased the rate of clinical progression and treatment failure.[21][Level of evidence A1] Hormonal approaches As noted above, studies have shown that chemotherapy with docetaxel or cabazitaxel and immunotherapy with sipuleucel-T can prolong OS in patients with hormone-sensitive or hormone-resistant metastatic prostate cancer
But lets not get ahead of ourselves, this could be a 1 in a million case
Diabetes 54 (1), 146151